About   Help   FAQ
Gene Expression Data
Assay Details
Assay
Reference: J:121435 Samokhvalov IM, et al., Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature. 2007 Apr 26;446(7139):1056-61
Assay type: Recombinase reporter
MGI Accession ID: MGI:5316128
Gene symbol: Runx1
Gene name: runt related transcription factor 1
Reporter: lacZ
Direct Detection
Assay notes: Tamoxifen was administered to pregnant mice during gestation at embryonic age specified in note, and embryos were assayed at age indicated.
Results
Specimen Fig. 1 E6.5 right: embryonic day 11.5-12.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E6.5. Embryos were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: embryo Absent 1_E6.5 induced No staining is observed with tamoxifen induction at E6.5.

Specimen not shown: embryonic day 11.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E6.5. Embryos were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: embryo Ambiguous No or very few stained blood cells are observed with tamoxifen treatment at E6.5.
TS19: yolk sac Present Spotted Some yolk sacs (2/16) contain clusters of stained visceral endodermal and endothelial cells and a few primitive blood cells.

Specimen Fig. 1 E7.5 right: embryonic day 11.5-12.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: embryo Present 1_E7.5 induced--left

Specimen Fig. 1 E7.5 right inset I: embryonic day 11.5-12.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: embryo Present 1_E7.5 induced--I Staining is observed in large numbers of blood cells in the embryonic circulation.
TS19: blood Present 1_E7.5 induced--I

Specimen Fig. 1 E7.5 right inset II: embryonic day 11.5-12.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos and maternal tissue were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: liver sinusoid Present 1_E7.5 induced--II Staining is observed in blood cells accumulating in the hepatic sinusoids with tamoxifen treatment at E7.5.

Specimen Fig. 1 E8.5 right: embryonic day 11.5-12.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.5. Embryos were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: blood Present 1_E8.5 induced Staining is observed in fewer circulating blood cells when tamoxifen is administered at E8.5 versus E7.5.
TS19: liver sinusoid Present 1_E8.5 induced Staining is observed in fewer blood cells in the liver when tamoxifen is administered at E8.5 versus E7.5.

Specimen Fig. 1 E9.5 right: embryonic day 11.5-12.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E9.5. Embryos were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: spinal ganglion Present 1_E9.5 induced--left Staining is observed in the spinal ganglia with tamoxifen induction at E9.5.
TS19: olfactory epithelium Present 1_E9.5 induced--left Staining is observed in the olfactory epithelium with tamoxifen induction at E9.5.
TS19: genital tubercle Present 1_E9.5 induced--left Staining is observed in the external genitalia primordium with tamoxifen induction at E9.5.
TS19: maxillary process Present 1_E9.5 induced--left Staining is observed with tamoxifen induction at E9.5.

Specimen Fig. 1 E9.5 right inset V: embryonic day 11.5-12.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E9.5. Embryos were isolated and stained on E11.5-12.0.
Structure Level Pattern Image Note
TS19: dorsal aorta Strong 1_E9.5 induced--V STaining is observed in the dorsal aorta endothelium and subjacent mesenchymal cells.

Specimen Fig. 2a: embryonic day 7.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Concepti were isolated and stained 4 hours after injection.
Structure Level Pattern Image Note
TS11: embryo Trace 2a Some stained cells are observed in some embryos at 4 hours after tamoxifen treatment.

Specimen Fig. 2b: embryonic day 7.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Concepti were isolated and stained 8 hours after injection.
Structure Level Pattern Image Note
TS11: embryo Present 2b Staining is observed in more embryos at 6 hours after tamoxifen treatment.
TS11: blood island Present Spotted 2b Staining is observed in more cells in the blood-island region at 6 hours after tamoxifen treatment.

Specimen Fig. 2c: embryonic day 8.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Concepti were isolated and stained 12 hours after injection.
Structure Level Pattern Image Note
TS12: yolk sac Present Regionally restricted 2c Staining is observed in a band of yolk sac cells in all embryos at 12 hours after tamoxifen treatment.

Specimen Fig. 2f: embryonic day 8.0; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Concepti were isolated and stained 12 hours after injection.
Structure Level Pattern Image Note
TS12: yolk sac Present Regionally restricted 2f Staining is observed exclusively in the proximal band of yolk sac cells adjacent to the extraembryonic ectoderm.

Specimen Fig. 4a: embryonic day 11.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos and maternal tissue were isolated and stained on E10.5-11.5.
Structure Level Pattern Image Note
TS19: umbilical vein Present 4a Staining is observed in cells in the endothelium of the umbilical vein with tamoxifen treatment at E7.5.

Specimen Fig. 4b: embryonic day 11.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos and maternal tissue were isolated and stained on E10.5-11.5.
Structure Level Pattern Image Note
TS19: umbilical artery Present 4b Staining is observed in cells in the endothelium of the umbilical artery with tamoxifen treatment at E7.5.

Specimen Fig. 4c: embryonic day 10.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos and maternal tissue were isolated and stained on E10.5-11.5.
Structure Level Pattern Image Note
TS17: dorsal aorta Present 4c Staining is observed in cells in the endothelium of dorsal aorta with tamoxifen treatment at E7.5.

Specimen Fig. S4A b: embryonic day 9.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos were isolated and stained on E9.5.
Structure Level Pattern Image Note
TS15: embryo Present Patchy S4A b Staining is observed in large numbers of blood cells in the embryo circulation.
TS15: yolk sac Present S4A b Staining is observed in cells in the yolk sac.
TS15: blood Present S4A b

Specimen Fig. S4A c right embryo: embryonic day 10.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E7.5. Embryos and yolk sacs were isolated and stained on E10.5.
Structure Level Pattern Image Note
TS17: embryo Present Patchy S4A c Staining is observed in large numbers of blood cells in the embryo circulation.
TS17: yolk sac Present S4A c

Specimen Fig. S5a: embryonic day 8.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.0. Embryos were isolated and stained 12 hours later.
Structure Level Pattern Image Note
TS13: yolk sac Present Spotted S5a Staining is observed only in the yolk sac at 12 hours after tamoxifen treatment at E8.0.

Specimen Fig. S5b: embryonic day 8.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.0. Embryos were isolated and stained 12 hours later.
Structure Level Pattern Image Note
TS13: yolk sac Present Spotted S5b Staining is observed only in the yolk sac at 12 hours after tamoxifen treatment at E8.0.

Specimen Fig. S5c: embryonic day 8.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.0. Embryos were isolated and stained 12 hours later.
Structure Level Pattern Image Note
TS13: yolk sac Present Spotted S5c Staining is observed only in the yolk sac at 12 hours after tamoxifen treatment at E8.0.

Specimen Fig. S5d: embryonic day 8.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.0. Embryos were isolated and stained 12 hours later.
Structure Level Pattern Image Note
TS13: yolk sac Present Spotted S5d Staining is observed only in the yolk sac vasculature at 12 hours after tamoxifen treatment at E8.0.
TS13: embryo Absent S5d No staining of intraembryonic cells from the caudal region is observed.

Specimen Fig. S5e: embryonic day 8.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.0. Embryos were isolated and stained 12 hours later.
Structure Level Pattern Image Note
TS13: yolk sac Present Spotted S5e Staining is observed only in the yolk sac at 12 hours after tamoxifen treatment at E8.0.
TS13: allantois Absent S5e
TS13: embryo Absent S5e

Specimen Fig. S5f: embryonic day 8.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.0. Embryos were isolated and stained 12 hours later.
Structure Level Pattern Image Note
TS13: embryo Absent S5f
TS13: yolk sac Present Spotted S5f
TS13: allantois Absent S5f

Specimen Fig. S5g: embryonic day 8.5; Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+, Runx1tm1(cre/Esr1*)Ims/Runx1+ (more )
Note: Conditional mutant. 5-10 mg of 4-hydroxytamoxifen (4-OHT) in sunflower oil was administered to pregnant mice by intraperitoneal injection at E8.0. Embryos were isolated and stained 12 hours later.
Structure Level Pattern Image Note
TS13: allantois Absent S5g No staining is observed in the allantois or embryo.
TS13: embryo Absent S5g No staining is observed in the allantois or embryo.


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/25/2025
MGI 6.24
The Jackson Laboratory